Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2024-11-18 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | AI Cycle · Pricing Power · Multiple Re-rating / 2026-01-26 RESEARCH
  • [Disclosure] SK Square (402340) – Decision on Disposal of Treasury Stocks / 2026-04-30 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders / 2025-12-16 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or News Reports (Unconfirmed) / 2025-11-14 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Other Management Matters (Voluntary Disclosure) / 2024-02-16 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Results of Measures Such as Prosecution Notice for Breach of Accounting Standards / 2025-02-04 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-03-25 Disclosures

[Disclosure] Celltrion (068270) – Change Listing (Retirement of Shares) / 2024-05-07

Posted on May 7, 2024August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion announced a change of listing scheduled for May 10, 2024, following the retirement of 1,119,924 common shares, reducing total issued shares to 216,929,838.

📊 [Key Disclosure Details & Financial Highlights]

  1. Change Listing Overview
  • Listed Security: Celltrion Common Stock
  • Reason for Change: Share Retirement
  • Retirement Date (Issue Date): April 26, 2024
  • Listing Date of Change: May 10, 2024
  • Par Value per Share: KRW 1,000
  • Dividend Accrual Date: January 01, 2024 (Fiscal Year-End: December 31)
  1. Share Count Variations
  • Shares Before Change: 218,049,762 shares
  • Change in Shares (Retired): -1,119,924 shares
  • Shares After Change: 216,929,838 shares (Tranche 127)
  1. Stock & Industry Codes
  • Standard Code: KR7068270008 (Short Code: 068270)
  • Industry Code: 03-21-01

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Change Listing and Total Issued Share Changes Post-Retirement

This disclosure reports a change in listing resulting from the retirement of shares. Verification of the reduction in total issued shares following the change of listing is important for tracking modifications in the company’s total share count. Detailed updates can be verified in subsequent disclosures and upcoming periodic reports (Quarterly, Half-Yearly, or Annual Reports).

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] SK Square(402340) – Clarification to Rumors or Reports (Unconfirmed) / 2024-05-07
Next Post: [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-05-08

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Earnings Release Notice / 2026-07-13 Disclosures
  • [Disclosure] Celltrion (068270) – Investor Relations (IR) Presentation / 2024-11-26 Disclosures
  • [Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Crohn’s Disease) / 2026-06-18 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Decision on Capital Increase / 2024-12-17 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Submission of Audit Report / 2025-03-13 Disclosures
  • [Disclosure] Hana Micron (067310) – Determination of 1st Preliminary Issue Price for Capital Increase / 2024-06-18 Semiconductors
  • [Disclosure] Celltrion (068270) – Decision on Cash Dividend / 2024-12-13 Disclosures
  • [Disclosure] Hana Micron (067310) – (Correction) Decision on Judgment/Decision on Lawsuit (Cancellation of General Meeting Resolution) / 2026-05-20 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Hana Securities | Resilient HBM · Early Commodity Stabilization · Target Price Raised / 2025-01-24 RESEARCH
  • [Disclosure] Celltrion (068270) – CT-P51 (Keytruda Biosimilar) Europe Phase 3 Early Termination & Voluntary Withdrawal of Trial Plan / 2026-07-14 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Clarification Regarding Rumors or Reports / 2026-07-22 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Hanwha Investment & Securities | High Quality Earnings · HBM3E Premium Monopoly · BUY Maintained / 2024-07-26 RESEARCH
  • [Disclosure] Celltrion (068270) – Occurrence of Serious Industrial Accident / 2026-03-23 Disclosures
  • [Disclosure] Celltrion (068270) – Provisional Sales Performance / 2025-05-09 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme